TRUMP GIVES BILLIONS IN HANDOUTS TO DRUG DEALERS

Pharmaceutical companies already spend more on marketing then they do on research. And most of their research is already subsidized by the government, and they're making record breaking profits anyway, so complaining about "the cost of research" is nonsensical.

If we are giving taxpayer money to private companies, that is a problem. There should be stricter rules on government-funded research with regard to patents, prices, etc. Without government aid, they should be able to charge however much they want, though.

Trump’s original spending proposal for fiscal year 2019, released last month, included major cuts to not just to the NIH, but the National Science Foundation as well. It is those two publicly funded entities — not Big Pharma — that support the bulk of the country’s basic research into diseases and pathways to new treatments.

That’s why the cuts were especially unwelcome in the executive suites of drug and biotech companies. Their business models depend on Washington subsidizing expensive, high-risk basic research, mostly through the vast laboratory network funded by the NIH.

Just how important is our publicly funded research to Big Pharma and Biotech? According to a new study by a small, partly industry-funded think tank called the Center for Integration of Science and Industry (CISI), it is existentially important.

No NIH funds, no new drugs, no patents, no profits, no industry.

This scam is worth a lot of money and is not easily messed with, as sacred as federal research benefiting military contractors. After Trump reversed his proposed research cuts last month, Bloomberg published an investor-soothing excuse article with the title, “The NIH appears Trump-proof.” The reporter, Max Nisen, explained, “NIH funds [are] a backbone of the research ecosystem on which [biotech and drug companies] depend. The better the NIH does, the better they do.” LINK

LINK TO CONVO

ZOMBIEBASICTRAINING

+proHUMAN +proFAMILY

Your scathing critique is requested.